SCHEMBL2224151

SCHEMBL2224151

O=C(NC1CC1)c1ccc(Cl)c([N+](=O)[O-])c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 2/20 0.65
POLB P06746 1/20 0.62
KMT2A Q03164 4/20 0.60
ALOX5 P09917 1/20 0.59
ALDH1A1 P00352 5/20 0.59
MAPT P10636 3/20 0.58
HTT P42858 3/20 0.58
MEN1 O00255 3/20 0.58
LMNA P02545 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
NPC1 O15118 1/20 0.57
MITF O75030 1/20 0.57
RAB9A P51151 1/20 0.57
KDM4E B2RXH2 1/20 0.56
HSP90AA1 P07900 1/20 0.56
HPGD P15428 1/20 0.56
HCAR3 P49019 1/20 0.55
MC4R P32245 1/20 0.53
MDM2 Q00987 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL240523 0.83 TSHR (0.63) POLBKMT2AALDH1A1MAPTMEN1
SCHEMBL31546610 0.83 POLB (0.62) POLBKMT2AALDH1A1MAPTHTT
SCHEMBL9501495 0.82 MEN1 (0.65) VCAM1POLBKMT2AALOX5ALDH1A1
SCHEMBL31229576 0.81 POLB (0.60) POLBKMT2AALDH1A1MAPTHTT
SCHEMBL27967569 0.80 VCAM1 (0.70) VCAM1KMT2AALDH1A1MAPTHTT
SCHEMBL844601 0.80 TSHR (0.63) POLBKMT2AALDH1A1MAPTMEN1
SCHEMBL9501514 0.80 ALDH1A1 (0.48) VCAM1POLBKMT2AALOX5ALDH1A1
SCHEMBL1258621 0.80 VCAM1 (1.00) VCAM1KMT2AALDH1A1MAPTHTT
SCHEMBL28871793 0.80 ALDH1A1 (0.59) VCAM1POLBKMT2AALDH1A1MAPT
SCHEMBL27660574 0.80 POLB (0.58) POLBKMT2AALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952004-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-10 US disclosed
US-20130029971-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-31 US disclosed
WO-2011084985-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029971-A1 CXCR3 RECEPTOR ANTAGONISTS CXCR3, CXCR1, CXCR2 VCAM1 203/4885POLB 2932/4885KMT2A 3936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.